Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.94 |
| ▸ | CASP7 | P55210 | 3/20 | 0.75 |
| ▸ | CASP3 | P42574 | 2/20 | 0.75 |
| ▸ | CASP6 | P55212 | 2/20 | 0.75 |
| ▸ | CASP8 | Q14790 | 2/20 | 0.75 |
| ▸ | CASP2 | P42575 | 1/20 | 0.75 |
| ▸ | PARP1 | P09874 | 4/20 | 0.56 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.56 |
| ▸ | FER | P16591 | 1/20 | 0.56 |
| ▸ | LTK | P29376 | 1/20 | 0.56 |
| ▸ | CDK8 | P49336 | 1/20 | 0.56 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.56 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.56 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 5/20 | 0.50 |
| ▸ | MAOB | P27338 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalimide SCHEMBL7771670 | 0.97 | GSK3B (1.00) | GSK3BCASP7CASP3CASP6CASP8 | |
| Phthalimide SCHEMBL11040503 | 0.97 | GSK3B (1.00) | GSK3BCASP7CASP3CASP6CASP8 | |
| Phthalimide SCHEMBL10192661 | 0.97 | GSK3B (1.00) | GSK3BCASP7CASP3CASP6CASP8 | |
| Phthalimide SCHEMBL29366030 | 0.97 | GSK3B (1.00) | GSK3BCASP7CASP3CASP6CASP8 | |
| Phthalimide SCHEMBL64 | 0.97 | GSK3B (1.00) | GSK3BCASP7CASP3CASP6CASP8 | |
| Phthalimide SCHEMBL30125197 | 0.97 | GSK3B (1.00) | GSK3BCASP7CASP3CASP6CASP8 | |
| Phthalimide SCHEMBL9561193 | 0.94 | GSK3B (0.94) | GSK3BCASP7CASP3CASP6CASP8 | |
| Phthalimide SCHEMBL7521027 | 0.94 | GSK3B (0.94) | GSK3BCASP7CASP3CASP6CASP8 | |
| Phthalimide SCHEMBL4297661 | 0.94 | GSK3B (0.94) | GSK3BCASP7CASP3CASP6CASP8 | |
| Phthalimide SCHEMBL14763935 | 0.94 | GSK3B (0.94) | GSK3BCASP7CASP3CASP6CASP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617161-B2 | Hybrid veil as interlayer in composite materials | CYTEC INDUSTRIES INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-12227628-B2 | Toughened composite materials capable of delamination propagation resistance | CYTEC INDUSTRIES INC. (US) | 2025-02-18 | — | — | US | disclosed |
| US-11745439-B2 | Hybrid veil as interlayer in composite materials | CYTEC INDUSTRIES INC. (US) | 2023-09-05 | — | — | US | disclosed |
| CN-113427841-B | Hybrid veil as an interlayer in composite materials | 塞特工业公司 | 2023-07-11 | — | — | CN | disclosed |
| US-20220347940-A1 | HYBRID VEIL AS INTERLAYER IN COMPOSITE MATERIALS | CYTEC INDUSTRIES INC | 2022-11-03 | — | — | US | disclosed |
| EP-3374165-B1 | HYBRID VEIL AS INTERLAYER IN COMPOSITE MATERIALS AND METHOD FOR MANUFACTURING A MODIFIED PREPREG COMPRISING A HYBRID VEIL | CYTEC IND INC (US) | 2022-04-20 | — | — | EP | disclosed |
| CN-109414839-A | Manufacture the method for extrusion film, manufacture film with and application thereof | 沙特基础工业全球技术有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-105813833-B | The composite of conductive and delamination resistance matter | 塞特工业公司 | 2017-09-01 | — | — | CN | disclosed |
| US-8507572-B2 | Functionalization of organic surfaces | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2013-08-13 | — | — | US | disclosed |
| US-20100331441-A1 | FUNCTIONALIZATION OF ORGANIC SURFACES | COLUMBIA UNIVERSITY (US) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331441-A1 | FUNCTIONALIZATION OF ORGANIC SURFACES | EPCAM, CD44, ILK | GSK3B 4543/4885CASP7 4026/4885CASP3 2864/4885 |
| US-12617161-B2 | Hybrid veil as interlayer in composite materials | VCL, RAD54L, EML4 | GSK3B 2050/4885CASP7 1219/4885CASP3 1950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.